Skip to content

Author

Ofer Levy

We have 3 of 104 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.

PURPOSE OF REVIEW This review highlights the rationale for and clinical experience in advancing age-specific adjuvantation systems to develop well tolerated and effective pediatric HIV vaccines. RECENT FINDINGS Due to both cellular and soluble factors, infant immunity is distinct from that of older children and adult...

K. Smolen, K. De Paris, Asimenia Angelidou et al. · 0 citations
Open access Aug 2026

Virus reactivation in acute and long COVID-19

Chronic viral infections are ubiquitous in humans, with individuals carrying multiple viruses that can reactivate during physiological stress, including severe illness1. Notably, SARS-CoV-2 infection has been shown to reactivate chronic viruses such as Epstein–Barr virus and cytomegalovirus, yet the full extent, tempor...

Cole P. Maguire, Jing Chen, Nadine Rouphael et al. · 3 citations
Open access Jul 2026

Advanced Machine Learning Across Multiple Vaccines to Predict Durable Immunogenicity using the Immune Signatures Data Resource 2260430

Understanding vaccine durability is key to designing immunizations with long-term efficacy. Leveraging the Immune Signatures Data Resource, a compendium of transcriptomic and immunological responses from 1405 healthy adults (18+ years) across 24 vaccines, we investigated shared immune mechanisms underlying durabl...

Marco Sanna, Jing Chen, Paolo Palma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.